Browse
Explore conditions, clinical trials, and the organisations running them.
Never miss a new study
Get alerted when new trials match your condition
Sign up free to track the conditions you care about and get a personal digest when new trials appear.
By submitting, you agree to our Terms of use
127005 trials found · Page 1209 of 6351
-
New HIV pill matches standard therapy in major trial
Disease control CompletedThis study will evaluate the safety and efficacy of a switch to MK-8591A (a fixed dose combination of doravirine and islatravir) in human immunodeficiency virus -1 (HIV-1)-infected participants virologically suppressed on a protocol-specified antiretroviral regimen. The primary h…
Phase 3 • Sponsor: Merck Sharp & Dohme LLC • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
New imaging device could reveal hidden bacteria in diabetic wounds
Disease control CompletedThis is a 12 week, randomized controlled trial. There are 2 arms and 20 patients with non healing diabetic foot ulcer allocated in each arm. One arm receives i:X guided treatment and the other arm receives standard of care treatment. Our primary objective is to compare the wound …
Sponsor: MolecuLight Inc. • Aim: Disease control
Last updated Jul 09, 2026 00:00 UTC
-
New drug cocktail shows promise for Hard-to-Treat thyroid cancer
Disease control OngoingThis phase II trial studies how well cabozantinib, nivolumab, and ipilimumab work in treating patients with differentiated thyroid cancer that does not respond to radioactive iodine and that worsened after treatment with a drug targeting the vascular endothelial growth factor rec…
Phase 2 • Sponsor: National Cancer Institute (NCI) • Aim: Disease control
Last updated Aug 02, 2026 00:00 UTC
-
Can Immune-Calming cells tame multiple sclerosis?
Disease control OngoingThe aim of this project is to assess properly the clinical efficacy of TolDec therapy by imaging, clinical and surrogate end-points related with the activity of the disease.
Phase 2 • Sponsor: Judit Pich • Aim: Disease control
Last updated Jun 27, 2026 09:06 UTC
-
Adding a Blood-Vessel blocker to maintenance chemo may extend control of advanced colorectal cancer
Disease control OngoingThe aim of BEVAMAINT is to improve benefic effect of maintenance therapy after a first line of induction chemotherapy for patients with colorectal cancer
Phase 3 • Sponsor: Centre Hospitalier Universitaire Dijon • Aim: Disease control
Last updated Jul 18, 2026 00:00 UTC
-
New MRI technique could revolutionize cystic fibrosis care
Disease control OngoingThe introduction of triple combination CFTR modulator therapy for patients with Cystic Fibrosis (CF) with at least one copy of the deltaF508 mutation is expected to provide major health benefits, but will also require novel outcome measures that can detect CF lung disease at an e…
Phase 4 • Sponsor: Children's Hospital Medical Center, Cincinnati • Aim: Disease control
Last updated Jun 27, 2026 08:08 UTC
-
New quadrivalent flu vaccine shows promise in large chinese trial
Prevention CompletedThe primary objectives of the study were: * To demonstrate the non-inferiority of the immune response in terms of geometric mean titers (GMTs) and seroconversion rates of the SP Shz QIV compared with the SP Shz TIV containing the Victoria lineage strain (TIV1) and the SP Shz TIV…
Phase 3 • Sponsor: Sanofi Pasteur, a Sanofi Company • Aim: Prevention
Last updated Jun 26, 2026 17:51 UTC
-
Could a simple injection dissolve painful calcium lumps in rare diseases?
Disease control Recruiting nowEctopic soft tissue calcifications or ossifications can complicate the course of numerous diseases; most of them are rare or very rare. Even if the clinical, radiological and pathological presentation of ectopic calcifications and ossifications are different, the same hypotheses …
Phase 2 • Sponsor: University Hospital, Limoges • Aim: Disease control
Last updated Jul 22, 2026 00:00 UTC
-
Can online or group programs stop teen depression before it starts?
Prevention OngoingPATH (Promoting AdolescenT Health) 2 Purpose is a two-arm comparative effectiveness research trial to that will evaluate the ability of the interventions, Competent Adulthood Transition with Cognitive-behavioral \& Interpersonal Training (CATCH-IT) and Teens Achieving Mastery ove…
Sponsor: University of Illinois at Chicago • Aim: Prevention
Last updated Jun 27, 2026 14:01 UTC
-
New laser system aims to sharpen vision for nearsighted patients
Disease control CompletedThis study will be a 3-phase, 12-months, prospective,single arm, multicenter, open-label, non-comparative, clinical investigation conducted at up to 7 sites. Up to 20 subjects will be enrolled in phase I, up to 30 subjects in phase II, and up to 200 subjects in phase 3 to achieve…
Sponsor: Johnson & Johnson Surgical Vision, Inc. • Aim: Disease control
Last updated Jun 27, 2026 08:05 UTC
-
New combo attack on hard-to-treat prostate cancer shows promise
Disease control CompletedThis phase II trial studies the how well apalutamide with or without stereotactic body radiation therapy work in treating participants with castration-resistant prostate cancer. Testosterone can cause the growth of prostate cancer cells. Hormone therapy using apalutamide may figh…
Phase 2 • Sponsor: University of California, San Francisco • Aim: Disease control
Last updated Jun 27, 2026 08:12 UTC
-
New device aims to prevent birth injuries during vaginal delivery
Disease control CompletedThis study is designed to evaluate the safety and effectiveness of the Materna Prep Device in reducing pelvic muscle injuries during vaginal delivery. Subjects are randomized to Materna Prep Device or Standard of Care without use of the Materna Prep Device Intervention with the…
Sponsor: Materna Medical • Aim: Disease control
Last updated Sep 02, 2026 00:00 UTC
-
New freezing device tackles stubborn heart rhythm disorder
Disease control CompletedClinical study to evaluate the safety and efficacy of the Adagio AF Cryoablation System (iCLAS™) in the ablation treatment of symptomatic, persistent atrial fibrillation (PsAF). Data will be used to support a pre-market application (PMA)
Sponsor: Adagio Medical • Aim: Disease control
Last updated Aug 08, 2026 00:03 UTC
-
New drug combo may reduce chronic transplant complications in blood cancer patients
Disease control CompletedThe purpose of this study is to investigate whether the combination of cyclophosphamide and abatacept versus the treatment used in standard of care will reduce the incidence of moderate and severe chronic graft-versus-host disease (GVHD) following hematopoietic stem cell transpla…
Phase 2 • Sponsor: Dimitrios Tzachanis, MD PhD • Aim: Disease control
Last updated Jun 27, 2026 07:53 UTC
-
5-Year study tracks brain implant for Parkinson's and tremor
Disease control Recruiting nowThe purpose of this international study is to evaluate long-term safety and effectiveness of Abbott deep brain stimulation (DBS) systems for all indications, including Parkinson's disease, essential tremor or other disabling tremor and dystonia.
Sponsor: Abbott Medical Devices • Aim: Disease control
Last updated Jun 27, 2026 08:09 UTC
-
New combo aims to free CML patients from daily pills
Disease control OngoingThe purpose of this study is to determine if adding Ruxolitinib to a Tyrone Kinase Inhibitor (TKI), prior to a second attempt at stopping a TKI will lead to prolonged treatment free remission (TFR).
Phase 2 • Sponsor: H. Lee Moffitt Cancer Center and Research Institute • Aim: Disease control
Last updated Jun 27, 2026 12:03 UTC
-
Blood test may spot hidden cancers years early
Knowledge-focused OngoingThis is a observational, multicenter study, monitoring the circulating tumor DNA (ctDNA) in people who is at risk of cancers,assessing the sensitivity and specificity of ctDNA detection in early screening of pan-carcinoma.
Sponsor: Geneplus-Beijing Co. Ltd. • Aim: Knowledge-focused
Last updated Jun 26, 2026 14:15 UTC
-
New Dual-Action antibody takes on Hard-to-Treat cancers
Disease control OngoingThis is a first-in-human, open-label, multicenter, Phase I multiple-ascending dose (MAD) study of RO7247669, an anti PD-1 (programmed death-1) and LAG-3 (Lymphocyte-activation gene 3) bispecific antibody, for participants with advanced and/or metastatic solid tumors. This study a…
Phase 1/2 • Sponsor: Hoffmann-La Roche • Aim: Disease control
Last updated Jun 27, 2026 14:00 UTC
-
Could bringing ADHD behavior therapy to the Doctor's office close the care gap for underserved kids?
Disease control CompletedThe purpose of this study is to address a decisional dilemma faced by health system officials, policy makers, and clinical leaders: "Does it make sense to integrate behavior therapy into primary care practice to treat children with ADHD from low-income settings? More specifically…
Sponsor: Children's Hospital of Philadelphia • Aim: Disease control
Last updated Jul 12, 2026 00:00 UTC
-
Brain bleed breakthrough? massive study tests surgery vs. standard care
Knowledge-focused Recruiting nowBackground: Although emergency surgery may reduce mortality in patients with severe spontaneous intracerebral hemorrhage (SSICH), the effectiveness and safety of surgical treatment among SSICH patients receiving long-term oral antiplatelet therapy (LOAPT) remain unclear. The CRIS…
Sponsor: Beijing Tiantan Hospital • Aim: Knowledge-focused
Last updated Jul 12, 2026 00:00 UTC